Skip to content

Alumis Inc. ALMS Operating Income

Operating Income at other companies

Amgen logo
AmgenAMGN
$2.67B+126%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
-$36.43M-45.2%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-$84.44M-34.6%
Vera Therapeutics logo
Vera TherapeuticsVERA
-$125.13M-119%
Dianthus Therapeutics logo
Dianthus TherapeuticsDNTH
-$46.53M-40.3%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-$3.65M+81.1%

Segments

By segment

See full
Single Reportable-$98.41M+3.1%

Other financials

Income statement

See full
Revenue$1.7M-90.0%
Net income-$93.1M+6.0%
EPS (diluted)-$0.74+59.3%

Balance sheet

See full
Cash & equivalents$63.9M-50.3%
Total debt$35.7M+1,881%
Total equity$567.0M+237%
Total assets$671.6M+157%

Cash flow

See full
Operating cash flow-$87.1M-8.4%
CapEx$164.0K+343%
Free cash flow-$87.2M-8.5%

Valuation

See full
Market cap$3.12B+739%
Enterprise value$3.1B+1,238%
P/S371.9×

Profitability

See full
Operating margin-5,364%
Net margin-2,825.7%
FCF margin-4,487.4%

Returns & leverage

See full
Return on equity-64.6%
Debt / equity0.1×+0.1×
Current ratio7.5×+3.8×

Where this comes from

Reported directly by Alumis Inc. in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Alumis Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alumis Inc.'s operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alumis Inc.'s operating income?
Alumis Inc. (ALMS) reported operating income of -$98.41M in Q1 2026.
How has Alumis Inc.'s operating income changed year-over-year?
Alumis Inc.'s operating income increased by 3.1% year-over-year, from -$101.53M to -$98.41M.
What is the long-term trend for Alumis Inc.'s operating income?
Over 2 years (2023 to 2025), Alumis Inc.'s operating income has grown at a 69.4% compound annual growth rate (CAGR), from -$158.17M to -$453.8M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.